We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+13.97%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$4.74B
AUM Growth
-$4.89B
Cap. Flow
-$187M
Cap. Flow %
-3.95%
Top 10 Hldgs %
49.48%
Holding
1,228
New
25
Increased
10
Reduced
14
Closed
23

Top Buys

Rank Stock Value
1
DHR.PRA
Danaher Corporation 4.75% Mandatory Convertible Preferred Stock, Series A
DHR.PRA
+$5.9M
2
SPLK
Splunk Inc
SPLK
+$2.26M
3
COUP
Coupa Software Incorporated
COUP
+$2.15M
4
BKNG icon
Booking.com
BKNG
+$1.8M
5
PPLI
People Inc
PPLI
+$1.64M

Top Sells

Rank Stock Value
1
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$11.1M
2
Z icon
Zillow
Z
+$3.18M
3
AGN
Allergan plc
AGN
+$2.69M
4
RNG icon
RingCentral
RNG
+$2.07M
5
REXR icon
Rexford Industrial Realty
REXR
+$2.04M

Sector Composition

Rank Sector Weight
1 Real Estate 58.33%
2 Technology 5.66%
3 Healthcare 4.64%
4 Consumer Discretionary 4.34%
5 Communication Services 4.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CYTK icon
1101
Cytokinetics
CYTK
$10.9B
$4K ﹤0.01%
363
– –
GMAB icon
1102
Genmab
GMAB
$17.7B
$4K ﹤0.01%
171
– –
GOSS icon
1103
Gossamer Bio
GOSS
$97.5M
$4K ﹤0.01%
373
– –
HCM icon
1104
HUTCHMED
HCM
$1.91B
$4K ﹤0.01%
235
– –
INO icon
1105
Inovio Pharmaceuticals
INO
$79.4M
$4K ﹤0.01%
47
– –
NTLA icon
1106
Intellia Therapeutics
NTLA
$1.49B
$4K ﹤0.01%
288
– –
OMER icon
1107
Omeros
OMER
$821M
$4K ﹤0.01%
309
– –
RCKT icon
1108
Rocket Pharmaceuticals
RCKT
$355M
$4K ﹤0.01%
284
– –
RYTM icon
1109
Rhythm Pharmaceuticals
RYTM
$7.28B
$4K ﹤0.01%
248
– –
SGMO
1110
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$4K ﹤0.01%
654
– –
STOK icon
1111
Stoke Therapeutics
STOK
$1.83B
$4K ﹤0.01%
185
– –
TVTX icon
1112
Travere Therapeutics
TVTX
$5.27B
$4K ﹤0.01%
263
– –
QTTB icon
1113
Q32 Bio
QTTB
$452M
$4K ﹤0.01%
14
– –
EGRX
1114
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$4K ﹤0.01%
82
– –
AERI
1115
DELISTED
Aerie Pharmaceuticals
AERI
$4K ﹤0.01%
261
– –
AKRO
1116
DELISTED
Akero Therapeutics
AKRO
$3K ﹤0.01%
161
– –
ANIP icon
1117
ANI Pharmaceuticals
ANIP
$1.78B
$3K ﹤0.01%
68
– –
ARDX icon
1118
Ardelyx
ARDX
$1.25B
$3K ﹤0.01%
494
– –
ATRA icon
1119
Atara Biotherapeutics
ATRA
$69.5M
$3K ﹤0.01%
12
– –
COLL icon
1120
Collegium Pharmaceutical
COLL
$1.15B
$3K ﹤0.01%
180
– –
CSTL icon
1121
Castle Biosciences
CSTL
$741M
$3K ﹤0.01%
96
– –
HP icon
1122
Helmerich & Payne
HP
$3.36B
$3K ﹤0.01%
213
– –
KURA icon
1123
Kura Oncology
KURA
$901M
$3K ﹤0.01%
288
– –
M icon
1124
Macy's
M
$6.57B
$3K ﹤0.01%
607
– –
PACB icon
1125
Pacific Biosciences
PACB
$422M
$3K ﹤0.01%
864
– –
43 44
45
46 47

Similar funds

SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

Daiwa Securities Group's Q2 2020 Portfolio in Review

As of Q2 2020, Daiwa Securities Group held 1,228 positions worth $4.74B, down 51% from $9.64B the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Daiwa Securities Group withdrew a net $187M in Q2 2020, closing 23 positions and reducing 14 holdings. Its most notable exit was Berkshire Hathaway Class B, an estimated $11.1M position sold in full.

By sector, the portfolio is most concentrated in Real Estate at 58% of assets, down from 71% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Daiwa Securities Group opened a new position in Danaher Corporation 4.75% Mandatory Convertible Preferred Stock, Series A worth $6.27M.

  • Daiwa Securities Group's largest Q2 2020 buy was Danaher Corporation 4.75% Mandatory Convertible Preferred Stock, Series A: 5,000 shares worth $6.27M.
  • Daiwa Securities Group added most to Splunk Inc in Q2 2020, an estimated $2.26M increase.
  • Daiwa Securities Group's biggest Q2 2020 reduction was Zillow, cutting an estimated $3.18M.
  • Daiwa Securities Group fully exited Berkshire Hathaway Class B in Q2 2020, selling an estimated $11.1M.
  • Daiwa Securities Group's ten largest holdings make up 49% of its $4.74B portfolio in Q2 2020.
  • Daiwa Securities Group opened 25 new positions and closed 23 in Q2 2020.
  • Daiwa Securities Group's portfolio value fell 51% quarter-over-quarter to $4.74B.

Based on Daiwa Securities Group's 13F filing for Q2 2020, filed 11 Aug 2020.